[Characteristics of human platelet fibrinogen receptors regulated by anti-CD9 monoclonal antibodies].
To investigate the regulatory effect of two anti-CD9 monoclonal antibodies (McAbs), HI117 and SJ9A4, on human platelet fibrinogen receptors, and explore their potential mechanisms. By using 125I-labeled human fibrinogen (Fg), the Fg specifically bound to human platelets induced by HI117 and SJ9A4 was measured, and the changes of anti-CD9 McAbs-exposed Fg receptor in the absence of Fg were also observed. HI117 (10 micrograms/ml) and SJ9A4 (20 micrograms/ml) induced markedly the specific binding of Fg to human platelets, suggesting that the two McAbs evoked obvious exposure of Fg receptors. But in the absence of Fg, the McAbs-exposed Fg receptors gradually lost their capacity to bind Fg and closed. Further study indicated that HI117 and SJ9A4-induced Fg binding was reduced by pretreatment of platelets with sphingosine, aspirin, apyrase, and/or PGI2. The anti-CD9 McAbs, HI117 and SJ9A4, can reversibly expose platelet Fg receptors, probably via three signaling pathways, i.e. thromboxane, secreted ADP and cAMP, protein kinase C (PKC) activation presumably being the common passage for the signaling.